Page 144 - Simplicity is Key in CRT

144
26. Haynes AB, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009;360(5):491-9.
27. Kydd AC, et al. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy). JACC Heart Fail 2014;2(3):205-12.
28. Ypenburg C, et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchro- nization therapy. J Am Coll Cardiol 2008;52(17):1402-9.
29. Delgado V, et al. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 2011;123(1):70-8.
30. Bleeker GB, et al. Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006;17(8):899-901.
31. Ypenburg C, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2007;28(1):33-41.
32. Adelstein E, et al. Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] trial). Am J Cardiol 2014;113(9):1518-22.
33. Gold MR, et al. The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchroni- zation therapy. J Cardiovasc Electrophysiol 2014;25(6):624-30.
34. Zanon F, et al. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2014;7(3):377-83.
35. Gold MR, et al. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resyn- chronization therapy. Eur Heart J 2011;32(20):2516-24.
36. Gold MR, et al. The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy. Heart Rhythm 2013;10(7):988-93.
37. Singh JP, et al. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm 2006;3(11):1285-92.
38. Forleo GB, et al. Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an im- plantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study. Europace 2015;17(1):101-7.
39. Forleo GB, et al. Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multiCentre prospective comparative study. J Interv Card Electro- physiol 2015;42(1):59-66.
40. Forleo GB, et al. Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multiCentre study. Heart Rhythm 2012;9(11):1822-8.
41. Behar JM, et al. Cardiac resynchronization therapy delivered via a multipolar left ventricular lead is associated with re- duced mortality and elimination of phrenic nerve stimulation: Long-term follow-up from a multiCentre registry. J Cardio- vasc Electrophysiol 2015.
42. Osca J, et al. The use of quadripolar left ventricular leads improves the hemodynamic response to cardiac resynchroniza- tion therapy. Pacing Clin Electrophysiol 2015;38(3):326-33.
43. Auger D, et al. Effect of atrioventricular and ventriculoventricular delay optimization on clinical and echocardiographic outcomes of patients treated with cardiac resynchronization therapy: a meta- analysis. Am Heart J 2013;166(1):20-9.
44. Sohaib SM, et al. Cardiac resynchronization therapy optimization strategies: systematic classification, detailed analysis, minimum standards and a roadmap for development and testing. Int J Cardiol 2013;170(2):118-31.
45. Kosmala W, Marwick TH. Meta-analysis of effects of optimization of cardiac resynchronization therapy on left ventricular function, exercise capacity, and quality of life in patients with heart failure. Am J Cardiol 2014;113(6):988-94.
46. Vernooy K,et al. Strategies to improve cardiac resynchronization therapy. Nat Rev Cardiol 2014;11(8):481-93.
47. Barold SS, Herweg B. Usefulness of the 12-lead electrocardiogram in the follow-up of patients with cardiac resynchroniza- tion devices. Part I. Cardiol J 2011;18(5):476-86.
48. Barold SS, Herweg B. Usefulness of the 12-lead electrocardiogram in the follow-up of patients with cardiac resynchroniza- tion devices. Part II. Cardiol J 2011;18(6):610-24.
49. Mullens W, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease manage- ment program. J Am Coll Cardiol 2009;53(9):765-73.